GoPro shares fall after going concern disclosure Jun 1, 2026 09:25AM
GoPro discloses substantial doubt about ability to continue operations Jun 1, 2026 09:17AM
Form SCHEDULE 13G BridgeBio Pharma, Inc. Filed by: Farallon Capital Partners, L.P. May 29, 2026 04:49PM
Assembly Biosciences prices $100 million stock offering at $26.50 per share May 22, 2026 07:05AM
InMed to merge with Mentari in $290 million migraine therapy deal May 19, 2026 08:06AM
View Older Stories

May 15, 2026 10:34AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
May 15, 2026 10:33AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
May 14, 2026 08:28AM Form SCHEDULE 13G InflaRx N.V. Filed by: Farallon Capital Partners, L.P.
May 12, 2026 08:54AM Form SCHEDULE 13G/A Tyra Biosciences, Inc. Filed by: Farallon Capital Partners, L.P.
May 12, 2026 08:51AM Form SCHEDULE 13G/A Beta Bionics, Inc. Filed by: Farallon Capital Partners, L.P.
May 11, 2026 08:52AM Form SCHEDULE 13G/A GRAIL, Inc. Filed by: Farallon Capital Partners, L.P.
May 11, 2026 08:49AM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
May 8, 2026 08:17AM InflaRx completes $150 million share offering at $2.00 per share
May 6, 2026 08:31AM InflaRx prices $150 million stock offering at $2 per share
Apr 27, 2026 07:15AM Sagimet prices $175 million stock offering at $6 per share
Apr 22, 2026 05:14AM Maze Therapeutics prices $150 million stock offering at $23.50 per share
Mar 6, 2026 05:17PM Form D/A Farallon Capital (AM)
Mar 6, 2026 05:15PM Form D/A Farallon Capital Partner
Mar 6, 2026 05:12PM Form D/A FARALLON CAPITAL OFFSHOR
Mar 6, 2026 05:05PM Form D/A Farallon Capital Institu
Feb 20, 2026 08:14AM Form SCHEDULE 13G Tyra Biosciences, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 17, 2026 10:57AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Dec 31
Feb 17, 2026 10:55AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
Feb 17, 2026 10:54AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Feb 17, 2026 10:53AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Feb 17, 2026 10:52AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
Feb 9, 2026 08:57AM Form SCHEDULE 13G/A Liquidia Corp Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:55AM Form SCHEDULE 13G/A AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:53AM Form SCHEDULE 13G/A Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:51AM Form SCHEDULE 13G/A Beta Bionics, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:49AM Form SCHEDULE 13G/A GRAIL, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 9, 2026 08:47AM Form SCHEDULE 13G/A ASSEMBLY BIOSCIENCES, Filed by: Farallon Capital Partners, L.P.
Feb 6, 2026 04:10PM Form SCHEDULE 13G/A Protagonist Therapeutics Filed by: Farallon Capital Partners, L.P.
Feb 5, 2026 03:00PM Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 5, 2026 03:00PM Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 5, 2026 02:57PM Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
Feb 5, 2026 02:54PM Form SCHEDULE 13G/A Savara Inc Filed by: Farallon Capital Partners, L.P.
Feb 5, 2026 02:51PM Form SCHEDULE 13G/A Minerva Neurosciences, Filed by: Farallon Capital Partners, L.P.
Feb 5, 2026 02:49PM Form SCHEDULE 13G/A ENANTA PHARMACEUTICALS Filed by: Farallon Capital Partners, L.P.
Feb 5, 2026 02:46PM Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: Farallon Capital Partners, L.P.
Jan 5, 2026 06:06PM Form SCHEDULE 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Dec 29, 2025 04:05PM Form SCHEDULE 13G Minerva Neurosciences, Filed by: Farallon Capital Partners, L.P.
Dec 5, 2025 08:31AM Freenome to go public via SPAC merger with $240 million funding
Nov 24, 2025 07:26PM Form SCHEDULE 13G GRAIL, Inc. Filed by: Farallon Capital Partners, L.P.
Nov 14, 2025 11:32AM Form N-PX/A FARALLON CAPITAL MANAGEM For: Jun 30
Nov 14, 2025 11:30AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Sep 30
Nov 14, 2025 11:29AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Nov 14, 2025 11:28AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Nov 14, 2025 11:28AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
Nov 14, 2025 11:27AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
Nov 14, 2025 11:27AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Nov 14, 2025 11:26AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Nov 14, 2025 11:26AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
Nov 14, 2025 11:24AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
Nov 13, 2025 09:47AM Form SCHEDULE 13G GRAIL, Inc. Filed by: Farallon Capital Partners, L.P.
View Older Stories